300458:SZSEAllwinner Technology Co., Ltd. Class A Analysis
Data as of 2026-07-22 - not real-time
CN¥40.66
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Allwinner Technology is trading well above its short‑ and long‑term moving averages, indicating a bullish price bias, but the MACD has turned bearish and the RSI is edging toward overbought territory, suggesting short‑term pressure near the recent resistance zone.
Fundamentally the company delivers robust top‑line growth and healthy operating margins, supported by a strong cash position and low leverage, yet its valuation metrics—particularly the price‑to‑earnings multiple—are markedly higher than the semiconductor industry average and the discounted cash‑flow model points to a far lower intrinsic value. The modest dividend yield combined with negative free cash flow raises questions about the sustainability of payouts.
Fundamentally the company delivers robust top‑line growth and healthy operating margins, supported by a strong cash position and low leverage, yet its valuation metrics—particularly the price‑to‑earnings multiple—are markedly higher than the semiconductor industry average and the discounted cash‑flow model points to a far lower intrinsic value. The modest dividend yield combined with negative free cash flow raises questions about the sustainability of payouts.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price approaching recent resistance level
- Bearish MACD crossover
- Elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and expanding margin profile
- Solid cash balance with minimal debt
- Low beta indicating limited market‑wide price swings
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic positioning in IoT, automotive and smart‑home semiconductor markets
- Potential for continued product diversification and market share gains
- Fundamental earnings upside despite current valuation premium
Key Metrics & Analysis
Financial Health
Revenue Growth47.10%
Profit Margin11.94%
P/E Ratio107.0
ROE11.65%
ROA5.48%
Debt/Equity2.77
P/B Ratio11.9
Op. Cash FlowCN¥382.1M
Free Cash FlowCN¥-84273096
Industry P/E33.8
Technical Analysis
TrendBullish
RSI59.5
SupportCN¥34.11
ResistanceCN¥43.13
MA 20CN¥38.51
MA 50CN¥36.34
MA 200CN¥35.72
MACDBearish
VolumeIncreasing
Fear & Greed Index90.98
Valuation
Fair ValueCN¥11.14
GradeOvervalued
TypeGrowth
Dividend Yield0.53%
Risk Assessment
Beta0.26
Volatility63.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.